| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95324407P | 2007-08-01 | 2007-08-01 | |
| PCT/SE2008/050901WO2009017456A1 (en) | 2007-08-01 | 2008-07-30 | Pharmaceutical composition suitable for adsorption to the cell surface of pathogenic microbes |
| Publication Number | Publication Date |
|---|---|
| EP2178540A1 EP2178540A1 (en) | 2010-04-28 |
| EP2178540A4true EP2178540A4 (en) | 2012-01-04 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP08779458AWithdrawnEP2178540A4 (en) | 2007-08-01 | 2008-07-30 | Pharmaceutical composition suitable for adsorption to the cell surface of pathogenic microbes |
| Country | Link |
|---|---|
| EP (1) | EP2178540A4 (en) |
| WO (1) | WO2009017456A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2753339A4 (en)* | 2011-07-22 | 2015-04-29 | Hjertén Maria | Capture of pathogenic and non-pathogenic biopolymers and bioparticles |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5382434A (en)* | 1991-03-12 | 1995-01-17 | Akzo N.V. | Low steroid dose dry pharmaceutical preparation |
| WO2001008792A2 (en)* | 1999-07-30 | 2001-02-08 | Genentech, Inc. | Charged filtration membranes and uses therefor |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9203435D0 (en)* | 1992-11-11 | 1992-11-11 | Georg Vlatakis Fondation For R | MANUFACTURING ARTIFICIAL ANTIBODIES WITH THE MOLECULE PRINTING METHOD AND THEIR USE IN ANALYSIS |
| US5728296A (en)* | 1996-03-20 | 1998-03-17 | Bio-Rad Laboratories, Inc. | Selective recognition of solutes in chromatographic media by artificially created affinity |
| US5846943A (en)* | 1996-11-08 | 1998-12-08 | Synsorb Biotech, Inc. | Solid support matricles containing a toxin binding oligosaccharide |
| IL162823A0 (en)* | 2002-01-03 | 2005-11-20 | Yissum Res Dev Co | Edible compositions capable of removing oral biofilm |
| CA2528861C (en)* | 2003-06-13 | 2012-08-21 | Torkel Wadstroem | Product for absorption purposes |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5382434A (en)* | 1991-03-12 | 1995-01-17 | Akzo N.V. | Low steroid dose dry pharmaceutical preparation |
| WO2001008792A2 (en)* | 1999-07-30 | 2001-02-08 | Genentech, Inc. | Charged filtration membranes and uses therefor |
| Title |
|---|
| See also references ofWO2009017456A1* |
| Publication number | Publication date |
|---|---|
| EP2178540A1 (en) | 2010-04-28 |
| WO2009017456A1 (en) | 2009-02-05 |
| Publication | Publication Date | Title |
|---|---|---|
| IL207955A0 (en) | Boron - containing small molecules as anti - inflammatory agents | |
| EP2212248A4 (en) | Process for the preparation of graphene | |
| IL201891A0 (en) | Novel pharmaceutical composition | |
| IL228817A0 (en) | Pharmaceutical composition | |
| ZA201004217B (en) | Use of bacteria for the production of bioenergy | |
| PT2374452T (en) | Nutrient composition | |
| AP2010005160A0 (en) | Improvements in or relating to organic compounds | |
| ZA201100653B (en) | Topical composition for the treatment of ctinic keratosis | |
| GB0803124D0 (en) | Improvements relating to benefit particles | |
| ZA201102715B (en) | Solid pharmaceutical composition | |
| EP2431038A4 (en) | Pharmaceutical composition containing arbidol in the form of phospholipid nanoparticles | |
| ZA201001774B (en) | Enriched nanostructure composition | |
| IL208387A0 (en) | Pharmaceutical composition | |
| AP2010005161A0 (en) | Improvements in or relating to organic compounds | |
| ZA201006766B (en) | Pharmaceutical composition 271 | |
| ZA201100871B (en) | Solid pharmaceutical composition | |
| IL211567A0 (en) | Use of stem cells to prevent neuronal dieback | |
| GB0818025D0 (en) | Granular composition | |
| ZA201006224B (en) | Pharmaceutical composition | |
| GB201015043D0 (en) | Novel napthalimide-benzimidazole hybrids as potential antitumour agents and process for the preparation thereof | |
| GB2464200B (en) | Pharmaceutical composition | |
| EP2178540A4 (en) | Pharmaceutical composition suitable for adsorption to the cell surface of pathogenic microbes | |
| PL386709A1 (en) | Purifying composition | |
| GB0817969D0 (en) | Pharmaceutical composition | |
| EP2236135A4 (en) | Stable pharmaceutical composition |
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| 17P | Request for examination filed | Effective date:20100216 | |
| AK | Designated contracting states | Kind code of ref document:A1 Designated state(s):AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR | |
| AX | Request for extension of the european patent | Extension state:AL BA MK RS | |
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched | Effective date:20111206 | |
| RIC1 | Information provided on ipc code assigned before grant | Ipc:A61K 9/14 20060101ALI20111130BHEP Ipc:A61P 31/04 20060101ALI20111130BHEP Ipc:A61K 31/74 20060101AFI20111130BHEP Ipc:A61K 39/395 20060101ALI20111130BHEP Ipc:A61P 31/12 20060101ALI20111130BHEP | |
| 17Q | First examination report despatched | Effective date:20140206 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN | |
| 18D | Application deemed to be withdrawn | Effective date:20160719 |